In addition, ACAT inhibition enhanced the function of TAA-specific CD8+ T cells in the surrounding liver tissue that might have the capacity to infiltrate and contribute to the anti-tumour response (Supplementary Fig. 4k). The gene discussed is CD8A; the disease is neoplasm.